Free Trial
TSE:MBX

Microbix Biosystems (MBX) Stock Price, News & Analysis

Microbix Biosystems logo
C$0.39 +0.03 (+8.33%)
As of 05/2/2025 04:16 PM Eastern

About Microbix Biosystems Stock (TSE:MBX)

Key Stats

Today's Range
C$0.35
C$0.39
50-Day Range
C$0.34
C$0.46
52-Week Range
C$0.29
C$0.55
Volume
97,273 shs
Average Volume
161,956 shs
Market Capitalization
C$51.36 million
P/E Ratio
14.86
Dividend Yield
2.30%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

Microbix Presenting at the 2025 Bloom Burton Conference
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Microbix Exhibiting at ESCMID Global 2025
Microbix Provides Business Updates
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

Microbix Biosystems' stock was trading at C$0.41 on January 1st, 2025. Since then, MBX shares have decreased by 4.9% and is now trading at C$0.39.
View the best growth stocks for 2025 here
.

Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbix Biosystems investors own include TransAlta Renewables (RNW), Moderna (MRNA), Canopy Growth (CGC), NightHawk Biosciences (NHWK), Organigram (OGI), VEON (VEON) and Vaxart (VXRT).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:MBX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
14.86
Forward P/E Ratio
19.50
P/E Growth
N/A
Net Income
C$3.39 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$24.42 million
Cash Flow
C$0.09 per share
Price / Cash Flow
4.13
Book Value
C$0.21 per share
Price / Book
1.89

Miscellaneous

Free Float
N/A
Market Cap
C$51.36 million
Optionable
Not Optionable
Beta
0.34
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (TSE:MBX) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners